A REVIEW ON PATIENTS WITH AORTIC REGURGITATION: PATHOPHYSIOLOGY, INVESTIGATIONS AND TREATMENT
OMAR ELSAKA *
Department of Cardiology, Mansoura University, Faculty of Medicine, Mansoura Manchester Medical Program (MMMP), Mansoura, Egypt.
MONEER AYMAN NOURELDEAN
Department of Cardiology, Mansoura University, Faculty of Medicine, Mansoura Manchester Medical Program (MMMP), Mansoura, Egypt.
MOHAMED ADEL GAMIL
Department of Cardiology, Mansoura University, Faculty of Medicine, Mansoura Manchester Medical Program (MMMP), Mansoura, Egypt.
MOSTAFA TAREK GHAZALI
Department of Cardiology, Mansoura University, Faculty of Medicine, Mansoura Manchester Medical Program (MMMP), Mansoura, Egypt.
ASHRAF HAMADA ABD AL-RAZIK
Department of Cardiology, Mansoura University, Faculty of Medicine, Mansoura Manchester Medical Program (MMMP), Mansoura, Egypt.
DALIA HISHAM
Department of Cardiology, Mansoura University, Faculty of Medicine, Mansoura Manchester Medical Program (MMMP), Mansoura, Egypt.
*Author to whom correspondence should be addressed.
Abstract
Background: Aortic regurgitation occurs when the aortic valve fails to close properly during diastole, allowing blood to flow backward through the valve. This condition can develop as a result of aortic root dilatation or as a result of a native valvular illness. This activity examines the diagnosis and treatment of aortic regurgitation, emphasizing the importance of the interprofessional team inpatient care.
Conclusion: The goal of this review article is to describe the pathophysiology of aortic regurgitation, outline the physical exam findings of aortic regurgitation, explain the treatment options for aortic regurgitation, and review the importance of collaboration and communication among interprofessional team members to improve outcomes for patients with aortic regurgitation.
Keywords: Placenta, Aortic regurgitation, Electrophoresis, echocardiography, LDH, surgical therapy, MDH, TAVR, GDH, aortic angiography
How to Cite
Downloads
References
Svensson LG, Adams DH, Bonow RO, et al. Aortic valve and ascending aorta guidelines for management and quality measures. Ann Thorac Surg. 2013;95 (6 Suppl):S1-66.
Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2012;33(19):2451-96.
Adachi O, Saiki Y, Akasaka J, Oda K, Iguchi A, Tabayashi K. Surgical management of aortic regurgitation associated with takayasu arteritis and other forms of aortitis. Ann Thorac Surg. 2007;84(6):1950-3.
Aggarwal A, Raghuvir R, Eryazici P, et al. The development of aortic insufficiency in continuous-flow left ventricular assist device-supported patients. Ann Thorac Surg. 2013; 95(2):493-8.
Aggarwal A, Raghuvir R, Eryazici P, et al. The development of aortic insufficiency in continuous-flow left ventricular assist device-supported patients. Ann Thorac Surg. 2013; 95(2):493-8.
Atalar E, Yorgun H, Canpolat U, et al. Prevalence of coronary artery disease before valvular surgery in patients with rheumatic valvular disease. Coron Artery Dis. 2012;23(8):533-7.
Babu AN, Kymes SM, Carpenter Fryer SM. Eponyms and the diagnosis of aortic regurgitation: what says the evidence?. Ann Intern Med. 2003;138(9):736-42.
Bekeredjian R, Grayburn PA. Valvular heart disease: aortic regurgitation. Circulation. 2005; 112(1):125-34.
Bhudia SK, McCarthy PM, Kumpati GS, et al. Improved outcomes after aortic valve surgery for chronic aortic regurgitation with severe left ventricular dysfunction. J Am Coll Cardiol. 2007;49(13):1465-71.
Chand EM, Freant LJ, Rubin JW. Aortic valve rheumatoid nodules producing clinical aortic regurgitation and a review of the literature. Cardiovasc Pathol. 1999;8(6):333-8.
Christ T, Grubitzsch H, Claus B, Konertz W. Long-term follow-up after aortic valve replacement with Edwards Prima Plus stentless bioprostheses in patients younger than 60 years of age. J Thorac Cardiovasc Surg. 2014;147(1):264-9.
de Meester C, Pasquet A, Gerber BL, et al. Valve repair improves the outcome of surgery for chronic severe aortic regurgitation: a propensity score analysis. J Thorac Cardiovasc Surg. 2014;148(5):1913-20.
Dujardin KS, Enriquez-Sarano M, Schaff HV, Bailey KR, Seward JB, Tajik AJ. Mortality and morbidity of aortic regurgitation in clinical practice. A long-term follow-up study. Circulation. 1999;99(14):1851-7.
Durko AP, Kappetein AP. Von Willebrand factor multimers during transcatheter aortic valve replacement-an additional clue for detecting post-procedural aortic regurgitation?. J Thorac Dis. 2016;8(12):E1697-E1700.
Eberhardt RT, Dhadly M. Giant cell arteritis: diagnosis, management, and cardiovascular implications. Cardiol Rev. 2007;15(2):55-61.
Feldman T. Rheumatic heart disease. Curr Opin Cardiol. 1996;11(2):126-30.
Franzone A, Piccolo R, Siontis GC, et al. Transcatheter aortic valve replacement for the treatment of pure native aortic valve regurgitation: a systematic review. JACC Cardiovasc Interv. 2016;9(22):2308-17.
Friedman T, Mani A, Elefteriades JA. Bicuspid aortic valve: clinical approach and scientific review of a common clinical entity. Expert Rev Cardiovasc Ther. 2008;6(2):235-48.
Gaztanaga J, Pizarro G, Sanz J. Evaluation of cardiac valves using multidetector CT. Cardiol Clin. 2009;27(4):633-44.
Harris AW, Krieger EV, Kim M, et al. Cardiac magnetic resonance imaging versus transthoracic echocardiography for prediction of outcomes in chronic aortic or mitral regurgitation. Am J Cardiol. 2017;119(7):1074-81.
Hiratzka LF, Creager MA, Isselbacher EM, et al. Surgery for aortic dilatation in patients with bicuspid aortic valves: A statement of clarification from the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2016;67(6):724-31.
Jain D, Halushka MK. Cardiac pathology of systemic lupus erythematosus. J Clin Pathol. 2009;62(7):584-92.
Jeserich M, Ihling C, Holubarsch C. Aortic valve endocarditis with Whipple disease. Ann Intern Med. 1997 ;126(11):920.
Kammerlander AA, Wiesinger M, Duca F, et al. Diagnostic and prognostic utility of cardiac magnetic resonance imaging in aortic regurgitation. JACC Cardiovasc Imaging. 2019;12(8 Pt 1):1474-83.
Keane MG, Pyeritz RE. Medical management of Marfan syndrome. Circulation. 2008; 117(21):2802-13.
Kolla KR, Larsen CM, Click RL, Chaliki HP, Maltais S. Pivotal role of intraoperative transesophageal echocardiography for detecting iatrogenic aortic regurgitation due to cardiac catheterization. Korean Circ J. 2018; 48(12):1160-2.
Lancellotti P, Tribouilloy C, Hagendorff A, et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 1: aortic and pulmonary regurgitation (native valve disease). Eur J Echocardiogr. 2010;11(3):223-44.
Lee JL, Naguwa SM, Cheema GS, Gershwin ME. Revisiting Libman-Sacks endocarditis: a historical review and update. Clin Rev Allergy Immunol. 2009;36(2-3):126-30.
Maurer G. Aortic regurgitation. Heart. 2006; 92(7):994-1000.
Morello A, Gelfand EV. Cardiovascular magnetic resonance imaging for valvular heart disease. Curr Heart Fail Rep. 2009;6(3):160-6.
Moyssakis I, Tektonidou MG, Vasilliou VA, Samarkos M, Votteas V, Moutsopoulos HM. Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution. Am J Med. 2007;120(7):636-42.
Myerson SG. Valvular and hemodynamic assessment with CMR. Heart Fail Clin. 2009;5(3):389-400.
Nishimura RA, Otto CM, Bonow RO, et al, for the ACC/AHA Task Force Members. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(23):e521-643.
Ortiz JT, Shin DD, Rajamannan NM. Approach to the patient with bicuspid aortic valve and ascending aorta aneurysm. Curr Treat Options Cardiovasc Med. 2006;8(6):461-7.
Orwat S, Diller GP, Kaleschke G, et al. Aortic regurgitation severity after transcatheter aortic valve implantation is underestimated by echocardiography compared with MRI. Heart. 2014;100(24):1933-8.
Palazzi C, D' Angelo S, Lubrano E, Olivieri I. Aortic involvement in ankylosing spondylitis. Clin Exp Rheumatol. 2008;26 (3 Suppl 49):S131-4.
Picano E, Pibarot P, Lancellotti P, Monin JL, Bonow RO. The emerging role of exercise testing and stress echocardiography in valvular heart disease. J Am Coll Cardiol. 2009; 54(24):2251-60.
Rahimtoola SH. Choice of prosthetic heart valve in adults an update. J Am Coll Cardiol. 2010;55(22):2413-26.
Roberts WC, Vowels TJ, Ko JM. Natural history of adults with congenitally malformed aortic valves (unicuspid or bicuspid). Medicine (Baltimore). 2012;91(6):287-308.
Salih HG, Ismail SR, Kabbani MS, Abu-Sulaiman RM. Predictors for the outcome of aortic regurgitation after cardiac surgery in patients with ventricular septal defect and aortic cusp prolapse in Saudi patients. Heart Views. 2016;17(3):83-7.
Sambola A, Tornos P, Ferreira-Gonzalez I, Evangelista A. Prognostic value of preoperative indexed end-systolic left ventricle diameter in the outcome after surgery in patients with chronic aortic regurgitation. Am Heart J. 2008;155(6):1114-20.
Sampat U, Varadarajan P, Turk R, Kamath A, Khandhar S, Pai RG. Effect of beta-blocker therapy on survival in patients with severe aortic regurgitation results from a cohort of 756 patients. J Am Coll Cardiol. 2009;54(5):452 -7.
Sato Y, Izumo M, Suzuki K, et al. Prognostic value of exercise left ventricular end-systolic volume index in patients with asymptomatic aortic regurgitation: an exercise echocardiography study. J Echocardiogr. 2017; 15(2):70-8.
Saura D, Penafiel P, Martinez J, et al. [The frequency of systolic aortic regurgitation and its relationship to heart failure in a consecutive series of patients]. Rev Esp Cardiol. 2008; 61(7):771-4.
Schirmer M, Weidinger F, Sandhofer A, Gschwendtner A, Wiedermann C. Valvular disease and myocardial infarctions in a patient with Behçet disease. J Clin Rheumatol. 2003; 9(5):316-20.
Singh JP, Evans JC, Levy D, et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol. 1999;83(6):897-902.
Sinning JM, Vasa-Nicotera M, Chin D, et al. Evaluation and management of paravalvular aortic regurgitation after transcatheter aortic valve replacement. J Am Coll Cardiol. 2013; 62(1):11-20.
Yeow WL, Roberts-Thomson P, Shetty S, Yong G. Expanding role for transcatheter aortic valve replacement: successful transfemoral implantation of a Medtronic CoreValve for severe aortic regurgitation. Heart Lung Circ. 2012;21(11):754-8.